Protagonist Therapeutics, Inc (PTGX)
NASDAQ · Manufacturing · Pharmaceutical preparations
$141.86+$4.52 (+3.29%) on the dayAs of the close; data may be delayed.
PTGX price, last 12 months
Key stats
- Previous close
- $137.34
- Open
- $138.82
- Day range
- $138.21 – $143.45
- 52-week range
- $62.24 – $160.81
- Volume
- 662.1K
- Avg volume (20 days)
- 660.7K
- Market cap
- $9.2B
Performance
1W−0.8%
1M−6.4%
3M+16.4%
6M+38.9%
YTD+62.4%
1Y+115.1%
vs S&P 500, 1Y+98.3 pts
Technicals and fundamentals
About Protagonist Therapeutics, Inc
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $9.2B